29 May 2024 --- Israeli biopharmaceutical company Mileutis has developed Imilac — an antibiotic substitute for dairy cows to reduce the dairy industry’s reliance on antibiotics. Trials involving 500 cows have shown the product’s ability to increase milk quality and yield to lower greenhouse gas (GHG) emissions and carbon footprint per kg of milk. Mileutis recently joined forces with Yotvata Dairy (partially owned by Strauss Group) to improve milk quality. Yotvata Dairy Farm will invest “millions of New Israeli Shekels” in the company and intends to “replace” the use of antibiotics for the treatment and prevention of infections with Imilac therapy in the Israeli dairy farms that supply it with milk.
